Work

Prospective Study of Immunomodulation with GM-CSF, IL-2, and Rituximab Following Autologous Stem Cell Transplant (SCT) in Patients with Relapsed Lymphomas.

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.918.918

Authors: Sonali M. Smith, David L. Grinblatt, Thomas Gajewski, Helena Harlin, Karen Welborne, Kathy Conner, Richard A. Larson, Elizabeth Rich, Olatoyosi Odenike, Todd Zimmerman, Koen van Besien

Institutions: University of Chicago, Northwestern University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2558024485

FWCI: 0.425

Cites:

Cited by: 2

Related to: 10